Both in Pharmaceuticals
PepGen vs Minerva Neurosciences
Over the past year PEPG returned −49.6% and NERV returned +59.5%; their daily moves had a correlation of 0.11.
PEPG −49.6% NERV +59.5%Growth of $1, one year, split-adjusted
| Metric | PEPG | NERV |
|---|---|---|
| Price | $2.34 | $3.35 |
| Market cap | $162.1M | $160.0M |
| Today | −9.65% | −1.47% |
| 1 month | −24.0% | −30.8% |
| 6 months | −44.7% | −43.9% |
| Year to date | −64.1% | −16.7% |
| 1 year | −53.8% | +58.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.2M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 90.4% | 77.9% |
| Short % of float | 9.7% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).